American CBA LLC

With all the focus in the media on pending legislation from Congress, less has been discussed about the implications from the CDC and FDA negotiating the reduction of cannabis from Schedule 1 to 3. Delve into the current changes in the cannabis industry with our webinar on what re-scheduling of cannabis as a schedule 1 drug. As the regulatory landscape surrounding cannabis continues to evolve, this webinar provides cannabis bankers with a comprehensive exploration of the potential impacts of cannabis re-scheduling.

Industry experts will dissect the legal and regulatory implications, offering insights into how these changes may reshape banking operations and open new avenues for growth. Join us to gain a nuanced understanding of the re-scheduling process and equip yourself with the knowledge needed to navigate this transformative moment in cannabis banking.

Key Learning Objectives:

• Legal Implications of Re-scheduling: Explore the potential legal changes associated with the re-scheduling of cannabis at the federal level.
• Impact on Banking Regulations: Understand how the re-scheduling may influence existing banking regulations and compliance requirements for cannabis-related transactions even with banks that are not currently banking cannabis
• Opportunities for Banking Expansion: Identify potential opportunities for banking expansion as regulatory barriers may evolve, allowing for broader financial engagement in the cannabis industry.
• Risk Mitigation Strategies: Learn strategies for mitigating risks associated with the changing regulatory landscape, including enhanced due diligence and compliance measures.
• Strategic Planning for the Future: Gain insights into how cannabis bankers can strategically plan for the future, anticipating and adapting to potential changes in cannabis re-scheduling and its broader implications.